Bharat Immunologicals & Biologicals Corporation Limited (BSE: 524663)
Health Care · Biotechnology · IN
Rs9.91
+13.52% today · -52.1% 1Y
Bharat Immunologicals & Biologicals Corporation Limited (BSE: 524663) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.51M.
Over the last twelve months the share price has lost 52.1%, trading between 7.11 and 22.61.
Tweenvest scores Bharat Immunologicals & Biologicals Corporation Limited across four factors: quality 48/100, value 48/100, growth 0/100. Its strongest factor is quality.
524663 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.51M
- Revenue (TTM)
- $920.80K
- P/E
- —
- EPS
- -4.28
- Dividend yield
- —
- Beta (5Y)
- 0.46
- 52-week high
- Rs22.61
- 52-week low
- Rs7.11
- Avg volume (3M)
- —
- Shares outstanding
- 43.18M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Stem Cells Spin S.A.WSE: SCS | $4.68M | zł0.44 | -10.20% |
| AFC Agro Biotech LimitedDSE: AFCAGRO | $4.67M | Tk5.00 | -12.28% |
| Xenetic Biosciences, Inc.NasdaqCM: XBIO | $4.66M | $1.99 | -6.57% |
| Vectus Biosystems LimitedASX: VBS | $4.54M | AU$0.11 | -4.55% |
| Predilife S.A.ENXTPA: ALPRE | $4.46M | €1.01 | +18.82% |
| Longeveron Inc.NasdaqCM: LGVN | $4.43M | $1.39 | -43.95% |
| Tecnovatica S.A.WSE: TEC | $4.42M | zł0.49 | -5.77% |
| Nymox Pharmaceutical CorporationOTCPK: NYMX.F | $4.41M | $0.04 | +31.25% |
Figures last refreshed Oct 18, 2026.